Keros Therapeutics (KROS) Capital Expenditures (QoQ) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -200.64% |
| Sep 30, 2025 | 354.63% |
| Jun 30, 2025 | -197.52% |
| Mar 31, 2025 | 95.50% |
| Dec 31, 2024 | -81.45% |
| Sep 30, 2024 | 1,167.12% |
| Jun 30, 2024 | -163.48% |
| Mar 31, 2024 | -57.33% |
| Dec 31, 2023 | 141.05% |
| Sep 30, 2023 | -197.12% |
| Jun 30, 2023 | 6,338.10% |
| Mar 31, 2023 | -98.29% |
| Dec 31, 2022 | 11,263.64% |
| Sep 30, 2022 | 82.54% |
| Jun 30, 2022 | -172.41% |
| Mar 31, 2022 | -45.28% |
| Dec 31, 2021 | 9.66% |
| Sep 30, 2021 | -79.86% |
| Dec 31, 2020 | 100.00% |
| Sep 30, 2020 | 7.14% |
| Jun 30, 2020 | -84.09% |
| Mar 31, 2020 | 877.78% |
| Dec 31, 2019 | -78.05% |
| Sep 30, 2019 | -52.05% |